| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/11/2003 | WO2003006656A3 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 12/11/2003 | WO2003002750A3 High throughput assay system |
| 12/11/2003 | WO2003002745A3 The cage gene of actinobacillus actinomycetemcomitans, the protein it encodes and uses thereof |
| 12/11/2003 | WO2003002730A3 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 12/11/2003 | WO2003001900A3 Process of controlled shuffling of chromosome fragments for plant breeding |
| 12/11/2003 | WO2003001882A3 Putative neurotransmitter receptor (pnr) disruptions, compositions and methods relating thereto |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2003000719A3 Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same |
| 12/11/2003 | WO2002101086A3 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
| 12/11/2003 | WO2002101064A3 Process for the preparation of d-pantothenic acid and/or salts thereof |
| 12/11/2003 | WO2002101056A3 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid |
| 12/11/2003 | WO2002099383A8 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
| 12/11/2003 | WO2002098914A3 Mutants of igf binding proteins and methods of production of antagonists thereof |
| 12/11/2003 | WO2002097096A3 Nucleotide sequences which code for the metd gene |
| 12/11/2003 | WO2002097085A3 Callus specific plant promoters |
| 12/11/2003 | WO2002096940A3 Attenuated very virulent infectious bursal disease virus |
| 12/11/2003 | WO2002094176A3 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments |
| 12/11/2003 | WO2002092785A3 Composition and methods relating to ovarian specific genes and proteins |
| 12/11/2003 | WO2002089567A3 Sca2 knockout animal and methods of use |
| 12/11/2003 | WO2002088387A3 Amplification process |
| 12/11/2003 | WO2002088305A3 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
| 12/11/2003 | WO2002086448B1 Detection of microsatellite instability and its use in diagnosis of tumors |
| 12/11/2003 | WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | WO2002083067A3 Prodrugs via acylation with cinnamate |
| 12/11/2003 | WO2002081658A3 Transgenic mice containing cacnb4 calcium ion channel gene disruptions |
| 12/11/2003 | WO2002077034A3 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 12/11/2003 | WO2002075507B1 Anti-bacterial vaccine compositions |
| 12/11/2003 | WO2002074989A3 Disease associated polymorphism in the ctla-4 locus |
| 12/11/2003 | WO2002070731A3 Methods and primers for evaluating hiv-1 mutations |
| 12/11/2003 | WO2002065943A3 Ocular tear growth factor-like protein |
| 12/11/2003 | WO2002065136A3 Yeast screens for agents affecting protein folding |
| 12/11/2003 | WO2002064788A3 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2002063975A3 Feed additive compositions and methods |
| 12/11/2003 | WO2002061108A3 Microorganisms and processes for enhanced production of pantothenate |
| 12/11/2003 | WO2002061085A3 Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |
| 12/11/2003 | WO2002060928A3 Medane genes and proteins |
| 12/11/2003 | WO2002057455A3 Nucleic acid sequences from drosophila melanogaster that encode proteins essential for larval viability and uses thereof |
| 12/11/2003 | WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/11/2003 | WO2002036623A3 Ghep, a gene highly expressed in normal and neoplastic prostate, and uses therefor |
| 12/11/2003 | WO2000070054A9 Pathogen-resistant grape plants |
| 12/11/2003 | US20030229925 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 12/11/2003 | US20030229924 Comprises nucleotide sequences coding arabidopsis late flowering protein (VIN4) for genetically engineering crops with increased yield and biomass |
| 12/11/2003 | US20030229923 Nucleic acid molecules encoding alternansucrase |
| 12/11/2003 | US20030229922 Comprises nucleotide sequences coding enzymatic polypeptide that modifies plant polysaccharides of cell wall for preparing cellulose acetate, synthetic textiles, biodegradable plastics and digestible medicine capsules |
| 12/11/2003 | US20030229921 Microbial beta-glucuronidase genes, gene products and uses thereof |
| 12/11/2003 | US20030229920 Gene silencing materials and methods |
| 12/11/2003 | US20030229919 Polypeptide compositions toxic to anthonomus insects, and methods of use |
| 12/11/2003 | US20030229918 Seed specific USP promoters for expressing genes in plants |
| 12/11/2003 | US20030229917 Phytic acid biosyntetic enzymes |
| 12/11/2003 | US20030229915 Plant gene sequences II |
| 12/11/2003 | US20030229913 Transgenic fish embryo with reduced endothelial growth factor (FLT1) expression for treating tumorous disorders; antisense therapy; angiogenesis inhibitors |
| 12/11/2003 | US20030229912 Non-human transgenic mammals and their use as a disease model |
| 12/11/2003 | US20030229911 Compositions and methods for wound healing |
| 12/11/2003 | US20030229910 Preparing transgenic cattle which are resistant to bovine spongioform encephalopathy; homologous recombination; animal husbandry; veterinary medicine |
| 12/11/2003 | US20030229909 Using nuclear transfer to propagate mammalian progeny/fetus; genetic engineering; animal models; veterinary medicine; animal husbandry |
| 12/11/2003 | US20030229908 Generating isogenic progenitor cells using nuclear transfer into enucleated oocytes for use as gene therapeutic tool in the treatment of cancer, muscular, nervous system, autoimmune and bone disorders; enzyme inhibitors; antiapoptosis |
| 12/11/2003 | US20030229907 Transgenic non-human mammals with progressive neurologic disease |
| 12/11/2003 | US20030229906 Preventing kidney cell dedifferentiation and viral nephropathy using peptide inhibitors; enzyme inhibitors; viricides; mimetics |
| 12/11/2003 | US20030229905 Generation of xenogeneic antibodies |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 12/11/2003 | US20030229903 Novel system for the evaluation of the activity and/or specificity of a viral component |
| 12/11/2003 | US20030229222 Improving process for isolating/purifying nucleotide sequences from viruses, bacteria, fungi, protozoa, plants and animals |
| 12/11/2003 | US20030229219 Preparation of phosphorothioate oligomers |
| 12/11/2003 | US20030229218 Synthons for oligonucleotide synthesis |
| 12/11/2003 | US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders |
| 12/11/2003 | US20030229215 Comprises nucleotide sequences coding transport proteins for use as tool in biological pest control; insecticides |
| 12/11/2003 | US20030229214 Comprises polynucleotide coding peptides or polypeptides associated with viral envelope protein for preventing infection and/or killing lymphadenopathy associated viral diseases; viricides; immunotherapy |
| 12/11/2003 | US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders |
| 12/11/2003 | US20030229208 Humanized immunoglobulins |
| 12/11/2003 | US20030229205 Silver halide emulsion for improving photographic products such as photographic paper or cellulose films |
| 12/11/2003 | US20030229204 PCG-1, a novel brown fat PPARgamma coactivator |
| 12/11/2003 | US20030229203 Chemokine variants and methods of use |
| 12/11/2003 | US20030229202 Comprises fusion protein for intracelluar delivery of compounds of interest into cells; drug delivery |
| 12/11/2003 | US20030229199 Modulator comprising cyclic peptide for use in treatment of cancer, gastrointestinal, inflammatory and nervous system disordrers |
| 12/11/2003 | US20030229068 Controlling apoptosis, cell proliferation; strokes; anticancer agents; central nervous system disorders |
| 12/11/2003 | US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance |
| 12/11/2003 | US20030229046 Genetic engineering; polynucleotides; translation of codon of human cytomegalo virus |
| 12/11/2003 | US20030229045 CFTR gene regulator |
| 12/11/2003 | US20030229043 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 12/11/2003 | US20030229041 Administering steroid compound |
| 12/11/2003 | US20030229040 Anticancer agents; complexing with lipids |
| 12/11/2003 | US20030229039 Gene therapy; mutant Dna |
| 12/11/2003 | US20030229038 Lunasin peptides |
| 12/11/2003 | US20030229034 Drug delivery; nucleic acids; complexing |
| 12/11/2003 | US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents |
| 12/11/2003 | US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies |
| 12/11/2003 | US20030229002 Use of agents that modulate PDE11A activity |
| 12/11/2003 | US20030228709 Arrays |
| 12/11/2003 | US20030228696 Novel insect cell line |
| 12/11/2003 | US20030228695 Cell-manipulating apparatus and method of using the same |
| 12/11/2003 | US20030228694 Transfection method and uses related thereto |
| 12/11/2003 | US20030228691 Processes for inhibiting gene expression using polynucleotides |
| 12/11/2003 | US20030228690 Antisense modulation of IL-1 receptor-associated kinase-1 expression |
| 12/11/2003 | US20030228689 Antisense modulation of G protein-coupled receptor kinase 6 expression |
| 12/11/2003 | US20030228688 Antisense modulation of isoprenylcysteine carboxyl methyltransferase expression |
| 12/11/2003 | US20030228686 Three dimensional vaginal tissue model containing immune cells |
| 12/11/2003 | US20030228678 Alleles of the aceA gene from coryneform bacteria |
| 12/11/2003 | US20030228676 Comprises nucleotide sequences coding proteolytic enzyme asociated with aggrecan degradation for treating degenerative joint diseases |
| 12/11/2003 | US20030228671 Fermenting lactic acid in kluyveromyces for use in cosmetics, pharmaceuticals, plastics and food production |
| 12/11/2003 | US20030228670 Synthetic enzymes for the production of coniferyl alcohol, coniferylaldehyde, ferulic acid, vanillin and vanillic acid and their use |